BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 27112358)

  • 21. Occlusion of the perimembranous ventricular septal defect using CERA® devices.
    Esteves CA; Solarewicz LA; Cassar R; Neves JR; Esteves V; Arrieta R
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):182-7. PubMed ID: 22431503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility and 1-year outcome of transcatheter closure of perimembranous ventricular septal defects with different devices.
    Shrestha M; Promphan W; Layangool T; Roymanee S; Wongwaitaweewong K; Prachasilchai P; Kirawittaya T; Sangtawesin C; Pattarakunwiwat P
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):E30-E37. PubMed ID: 30269417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Closure of perimembranous ventricular septal defects with aneurysmal tissue using the Amplazter Duct Occluder I: lessons learned and medium term follow up.
    El Said HG; Bratincsak A; Gordon BM; Moore JW
    Catheter Cardiovasc Interv; 2012 Nov; 80(6):895-903. PubMed ID: 22907908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and Safety of Transcatheter Closure of Perimembranous Ventricular Septal Defects in Adults.
    Wang J; Zuo J; Yu S; Yi D; Yang X; Zhu X; Li J; Yang L; Xiong L; Ge S; Ren J; Yang J
    Am J Cardiol; 2016 Mar; 117(6):980-7. PubMed ID: 26796197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arrhythmias after transcatheter closure of perimembranous ventricular septal defects with a modified double-disk occluder: early and long-term results.
    Li P; Zhao XX; Zheng X; Qin YW
    Heart Vessels; 2012 Jul; 27(4):405-10. PubMed ID: 21643813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcatheter closure of perimembranous ventricular septal defects in infants and children using the Amplatzer perimembranous ventricular septal defect occluder.
    Thanopoulos BV; Rigby ML; Karanasios E; Stefanadis C; Blom N; Ottenkamp J; Zarayelyan A
    Am J Cardiol; 2007 Apr; 99(7):984-9. PubMed ID: 17398197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The morphologic changes of Amplatzer asymmetric ventricular septal defect occluder after transcatheter closure of perimembrane ventricular septal defect].
    Ma YT; Yang YN; Tang BP; Huang D; Mu YM; Ma X; Liu X
    Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):817-20. PubMed ID: 15631704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Off-label use of duct occluder devices to close hemodynamically significant perimembranous ventricular septal defects: A multicenter experience.
    Udink Ten Cate FEA; Sobhy R; Kalantre A; Sachdev S; Subramanian A; Koneti NR; Kumar RK; Hamza H; Jayranganath M; Sreeram N
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):82-88. PubMed ID: 30208249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amplatzer duct occluder II for closure of congenital Gerbode defects.
    Vijayalakshmi IB; Natraj Setty HS; Chitra N; Manjunath CN
    Catheter Cardiovasc Interv; 2015 Nov; 86(6):1057-62. PubMed ID: 26152234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrograde transcatheter closure of ventricular septal defects in children using the Amplatzer Duct Occluder II.
    Koneti NR; Penumatsa RR; Kanchi V; Arramraj SK; S J; Bhupathiraju S
    Catheter Cardiovasc Interv; 2011 Feb; 77(2):252-9. PubMed ID: 20578168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitral and aortic valve regurgitation following surgical and transcatheter perimembranous ventricular septal defect closure in children and adolescents: midterm outcomes.
    Edraki M; Nobakhti M; Naghshzan A; Amoozgar H; Amirghofran A; Ghasemzadeh B; Nirooie E; Mehdizadegan N; Mohammadi H; Keshavarz K
    BMC Cardiovasc Disord; 2022 Jul; 22(1):315. PubMed ID: 35840901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcatheter closure of perimembranous and intracristal ventricular septal defects with the SHSMA occluder.
    Zhou D; Pan W; Guan L; Ge J
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):666-74. PubMed ID: 22109986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcatheter trans-septal antegrade closure of muscular ventricular septal defects in young children.
    Koneti NR; Verma S; Bakhru S; Vadlamudi K; Kathare P; Penumatsa RR; Qureshi S
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E500-6. PubMed ID: 23704080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early migration of an Amplatzer muscular ventricular septal defect occluder device causing severe tricuspid valve obstruction.
    Panduranga P; Al-Farqani A; Al-Maskari S
    J Cardiovasc Med (Hagerstown); 2012 May; 13(5):336-7. PubMed ID: 22089813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Complications of transcatheter interventional occlusion of ventricular septal defects].
    Zhang YS; Li H; Liu JP; Dai ZX; Wang L; Zhang J; Li J; Wang XY
    Zhonghua Er Ke Za Zhi; 2005 Jan; 43(1):35-8. PubMed ID: 15796806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postimplant complications with transcatheter closure of congenital perimembranous ventricular septal defects: a single-center, longitudinal study from 2002 to 2011.
    Jin Y; Han B; Zhang J; Zhuang J; Yan J; Wang Y
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):666-73. PubMed ID: 22936471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of transcatheter closure by Amplatzer
    Wongwaitaweewong K; Promphan W; Roymanee S; Prachasilchai P
    Cardiovasc Interv Ther; 2021 Jul; 36(3):375-383. PubMed ID: 32462466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perventricular device closure of perimembranous ventricular septal defects in 61 young children: early and midterm follow-up results.
    Tao K; Lin K; Shi Y; Song H; Lui RC; Gan C; An Q
    J Thorac Cardiovasc Surg; 2010 Oct; 140(4):864-70. PubMed ID: 20561638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perimembranous Ventricular Septal Defect Device Closure: Choosing Between Amplatzer Duct Occluder I and II.
    El-Sisi A; Sobhy R; Jaccoub V; Hamza H
    Pediatr Cardiol; 2017 Mar; 38(3):596-602. PubMed ID: 28251252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry.
    Holzer R; de Giovanni J; Walsh KP; Tometzki A; Goh T; Hakim F; Zabal C; de Lezo JS; Cao QL; Hijazi ZM
    Catheter Cardiovasc Interv; 2006 Oct; 68(4):620-8. PubMed ID: 16969878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.